腹腔感染管理:意大利优化抗菌药物使用委员会推荐
该共识由意大利优化抗菌药物使用多学科跨学会委员会推动,涵盖急诊医学、影像学、外科、重症医学、感染病学、临床药理学、医院药学、微生物学及公共卫生专家。专家小组基于PubMed和EMBASE图书馆的最佳科学证据及专家意见制定推荐声明,按GRADE证据分级体系进行规划和分级,于2023年11月10日在意大利梅斯特雷开会辩论,最终文件包括三部分:腹腔感染诊断与治疗的一般原则、23条循证抗菌治疗推荐、8条常见腹腔感染临床诊断-治疗路径。文件已获意大利外科学会认可。
要点
- 腹腔感染管理的基石包括早期诊断、充分的感染源控制、恰当的抗菌治疗以及危重患者使用静脉液体和血管加压药进行早期生理稳定。
- 恰当的 empiric 抗菌治疗至关重要,不恰当的抗菌治疗与不良结局相关。
- 优化抗菌药物处方可提高治疗效果、增加患者安全性,并减少机会性感染(如艰难梭菌)和抗菌药物耐药选择的风险。
- 多药耐药革兰阴性菌的日益出现已造成紧迫危机,具有警示性影响。
- 共识文件包含23条基于证据的腹腔感染抗菌治疗推荐和8条常见腹腔感染临床诊断-治疗路径。
适用人群与场景
- 腹腔感染患者,尤其是医院环境中管理不善时发病率和死亡率高。
- 危重患者接受静脉液体和血管加压药进行早期生理稳定。
处置流程与药物剂量
- 早期诊断。
- 充分的感染源控制。
- 恰当的抗菌治疗。
- 危重患者使用静脉液体和血管加压药进行早期生理稳定。
研究设计与关键结果
- 共识会议制定了推荐声明,基于PubMed和EMBASE图书馆的最佳科学证据及专家意见,按GRADE证据分级体系进行规划和分级。
- 文件包括三部分:第一部分聚焦腹腔感染诊断与治疗的一般原则;第二部分提供23条基于证据的腹腔感染抗菌治疗推荐;第三部分呈现8条最常见腹腔感染的临床诊断-治疗路径。
证据类型、等级与局限
- 证据类型:共识会议(指南)。
- 推荐声明基于PubMed和EMBASE图书馆的最佳科学证据及专家意见,按GRADE证据分级体系进行规划和分级。
- 文件已获意大利外科学会认可。
对床旁实践的改变
- 对腹腔感染患者应实施早期诊断、充分感染源控制、恰当抗菌治疗,危重患者使用静脉液体和血管加压药进行早期生理稳定。
- 优化抗菌药物处方以提高治疗效果、增加患者安全性,并减少机会性感染(如艰难梭菌)和抗菌药物耐药选择的风险。
指南或共识出处
- 意大利优化抗菌药物使用多学科跨学会委员会腹腔感染抗菌管理共识会议执行摘要,2023年11月10日于意大利梅斯特雷辩论,获意大利外科学会认可。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Intra-abdominal infections (IAIs) are common surgical emergencies and are an important cause of morbidity and mortality in hospital settings, particularly if poorly managed. The cornerstones of effective IAIs management include early diagnosis, adequate source control, appropriate antimicrobial therapy, and early physiologic stabilization using intravenous fluids and vasopressor agents in critically ill patients. Adequate empiric antimicrobial therapy in patients with IAIs is of paramount importance because inappropriate antimicrobial therapy is associated with poor outcomes. Optimizing antimicrobial prescriptions improves treatment effectiveness, increases patients' safety, and minimizes the risk of opportunistic infections (such as Clostridioides difficile) and antimicrobial resistance selection. The growing emergence of multi-drug resistant organisms has caused an impending crisis with alarming implications, especially regarding Gram-negative bacteria. The Multidisciplinary and Intersociety Italian Council for the Optimization of Antimicrobial Use promoted a consensus conference on the antimicrobial management of IAIs, including emergency medicine specialists, radiologists, surgeons, intensivists, infectious disease specialists, clinical pharmacologists, hospital pharmacists, microbiologists and public health specialists. Relevant clinical questions were constructed by the Organizational Committee in order to investigate the topic. The expert panel produced recommendation statements based on the best scientific evidence from PubMed and EMBASE Library and experts' opinions. The statements were planned and graded according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) hierarchy of evidence. On November 10, 2023, the experts met in Mestre (Italy) to debate the statements. After the approval of the statements, the expert panel met via email and virtual meetings to prepare and revise the definitive document. This document represents the executive summary of the consensus conference and comprises three sections. The first section focuses on the general principles of diagnosis and treatment of IAIs. The second section provides twenty-three evidence-based recommendations for the antimicrobial therapy of IAIs. The third section presents eight clinical diagnostic-therapeutic pathways for the most common IAIs. The document has been endorsed by the Italian Society of Surgery.
参考来源
- Sartelli M, Tascini C, Coccolini F, et al. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use. World J Emerg Surg. 2024. PMID: 38851757. doi:10.1186/s13017-024-00551-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。